Show simple item record

dc.contributor.authorFarwa Batool
dc.contributor.authorMuhammad Saeed
dc.contributor.authorHafiza Nosheen Saleem
dc.contributor.authorLuisa Kirschner
dc.contributor.authorJochen Bodem
dc.contributor.otherDepartment of Chemistry and Chemical Engineering, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore 54692, Pakistan
dc.contributor.otherDepartment of Chemistry and Chemical Engineering, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore 54692, Pakistan
dc.contributor.otherDepartment of Chemistry and Chemical Engineering, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore 54692, Pakistan
dc.contributor.otherInstitut für Virologie und Immunbiologie, Versbacher Straße 7, 97078 Würzburg, Germany
dc.contributor.otherInstitut für Virologie und Immunbiologie, Versbacher Straße 7, 97078 Würzburg, Germany
dc.date.accessioned2025-10-09T05:32:43Z
dc.date.available2025-10-09T05:32:43Z
dc.date.issued01-04-2021
dc.identifier.urihttps://www.mdpi.com/2076-0817/10/4/464
dc.identifier.urihttp://digilib.fisipol.ugm.ac.id/repo/handle/15717717/41149
dc.description.abstractSeveral new <i>N</i>-substituted 1,2-benzisothiazol-3(2<i>H</i>)-ones (BITs) were synthesised through a facile synthetic route for testing their anti-dengue protease inhibition. Contrary to the conventional multistep synthesis, we achieved structurally diverse BITs with excellent yields using a two-step, one-pot reaction strategy. All the synthesised compounds were prescreened for drug-like properties using the online Swiss Absorption, Distribution, Metabolism and Elimination (SwissADME) model, indicating their favourable pharmaceutical properties. Thus, the synthesised BITs were tested for inhibitory activity against the recombinant dengue virus serotype-2 (DENV-2) NS2BNS3 protease. Dose–response experiments and computational docking analyses revealed that several BITs bind to the protease in the vicinity of the catalytic triad with IC<sub>50</sub> values in the micromolar range. The DENV2 infection assay showed that two BITs, 2-(2-chlorophenyl)benzo[d]isothiazol-3(2<i>H</i>)-one and 2-(2,6-dichlorophenyl)benzo[<i>d</i>]isothiazol-3(2<i>H</i>)-one, could suppress DENV replication and virus infectivity. These results indicate the potential of BITs for developing new anti-dengue therapeutics.
dc.language.isoEN
dc.publisherMDPI AG
dc.subject.lccMedicine
dc.titleFacile Synthesis and In Vitro Activity of <i>N</i>-Substituted 1,2-Benzisothiazol-3(2<i>H</i>)-ones against Dengue Virus NS2BNS3 Protease
dc.typeArticle
dc.description.keywordsdengue virus
dc.description.keywordsdirect-acting antivirals
dc.description.keywords1,2-benzisothiazolinone
dc.description.keywordsdrug discovery
dc.description.keywordsinfectivity assays
dc.description.doi10.3390/pathogens10040464
dc.title.journalPathogens
dc.identifier.e-issn2076-0817
dc.identifier.oaioai:doaj.org/journal:d8fe8a89ce6043eeb3ebe3b51c0230f9
dc.journal.infoVolume 10, Issue 4


This item appears in the following Collection(s)

Show simple item record